References: Lithium, sodium valproate or carbamazepine for acute mania in adults and young people

  • Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 2006;163(2):272–5 .https://pubmed.ncbi.nlm.nih.gov/16449481
  • Balance investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010;375(9712):385–95. https://www.ncbi.nlm.nih.gov/pubmed/20092882
  • Baldessarini RJ, Tondo L, Vazquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry 2019;24(2):198–217. https://www.ncbi.nlm.nih.gov/pubmed/29679069
  • Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994;271(12):918–24. https://www.ncbi.nlm.nih.gov/pubmed/8120960
  • Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 2018;51(1-02):9–62. https://www.ncbi.nlm.nih.gov/pubmed/28910830